529
Views
13
CrossRef citations to date
0
Altmetric
Review

A Review of Advancements and Evidence Gaps in Diabetic Retinopathy Screening Models

& ORCID Icon
Pages 3285-3296 | Published online: 14 Oct 2020

References

  • International Diabetes Federation. IDF Diabetes Atlas. 9th ed. Brussels, Belgium; 2019. Available from http://www.diabetesatlas.org. Accessed July 15, 2020.
  • Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet. 2010;376(9735):124–136. doi:10.1016/S0140-6736(09)62124-3
  • Liew G, Michaelides M, Bunce C. A comparison of the causes of blindness certifications in England and Wales in working age adults (16–64 years), 1999–2000 with 2009–2010. BMJ Open. 2014;4(2):e004015. doi:10.1136/bmjopen-2013-004015
  • Solomon SD, Chew E, Duh EJ, et al. Diabetic retinopathy: a position statement by the American diabetes association. Diabetes Care. 2017;40(3):412–418. doi:10.2337/dc16-2641
  • Deschler EK, Sun JK, Silva PS. Side-effects and complications of laser treatment in diabetic retinal disease. Semin Ophthalmol. 2014;29(5–6):290–300. doi:10.3109/08820538.2014.959198
  • Campochiaro PA, Brown DM, Pearson A, et al. Sustained delivery fluocinolone acetonide vitreous inserts provide benefit for at least 3 years in patients with diabetic macular edema. Ophthalmology. 2012;119(10):2125–2132. doi:10.1016/j.ophtha.2012.04.030
  • Lu Q, Lu L, Chen B, Chen W, Lu P. Efficacy comparison of intravitreal injections of conbercept and ranibizumab for severe proliferative diabetic retinopathy. Can J Ophthalmol. 2019;54(3):291–296. doi:10.1016/j.jcjo.2018.06.010
  • Bolinger MT, Antonetti DA. Moving past anti-VEGF: novel therapies for treating diabetic retinopathy. Int J Mol Sci. 2016;17(9):pii: E1498. doi:10.3390/ijms17091498
  • Romero-Aroca P, Navarro-Gil R, Valls-Mateu A, Sagarra-Alamo R, Moreno-Ribas A, Soler N. Differences in incidence of diabetic retinopathy between type 1 and 2 diabetes mellitus: a nine-year follow-up study. Br J Ophthalmol. 2017;101(10):1346–1351. doi:10.1136/bjophthalmol-2016-310063
  • Thomas RL, Dunstan FD, Luzio SD, et al. Prevalence of diabetic retinopathy within a national diabetic retinopathy screening service. Br J Ophthalmol. 2015;99(1):64–68. doi:10.1136/bjophthalmol-2013-304017
  • CDC. National Diabetes Statistics Report, 2020: estimates of diabetes and its burden in the United States; 2020. Available from: https://www.cdc.gov/diabetes/pdfs/data/statistics/national-diabetes-statistics-report.pdf. Accessed July 15, 2020.
  • Scanlon PH. The English National Screening Programme for diabetic retinopathy 2003–2016. Acta Diabetol. 2017;54(6):515–525. doi:10.1007/s00592-017-0974-1
  • Fung MM, Yap MK, Cheng KK. Community-based diabetic retinopathy screening in Hong Kong: ocular findings. Clin Exp Optom. 2011;94(1):63–66. doi:10.1111/j.1444-0938.2010.00552.x
  • Jones S, Edwards RT. Diabetic retinopathy screening: a systematic review of the economic evidence. Diabet Med. 2010;27(3):249–256. doi:10.1111/j.1464-5491.2009.02870.x
  • Scanlon PH, Aldington SJ, Leal J, et al. Development of a cost-effectiveness model for optimisation of the screening interval in diabetic retinopathy screening. Health Technol Assess. 2015;19(74):1–116. doi:10.3310/hta19740
  • Royle P, Mistry H, Auguste P, et al. Pan-retinal photocoagulation and other forms of laser treatment and drug therapies for non-proliferative diabetic retinopathy: systematic review and economic evaluation. Health Technol Assess. 2015;19(51):v–xxviii, 1–247. doi:10.3310/hta19510
  • Owsley C, McGwin G Jr., Lee DJ, et al. Diabetes eye screening in urban settings serving minority populations: detection of diabetic retinopathy and other ocular findings using telemedicine. JAMA Ophthalmol. 2015;133(2):174–181. doi:10.1001/jamaophthalmol.2014.4652
  • Nielsen N, Jackson C, Spurling G, Cranstoun P. Nondiabetic retinal pathology - prevalence in diabetic retinopathy screening. Aust Fam Physician. 2011;40(7):529–532.
  • National Institute for Health and Care Excellence (NICE). Type 2 diabetes in adults: management. Clinical Guideline; 2019. Available from: https://www.nice.org.uk/guidance/ng28. Accessed July 15, 2020.
  • American Diabetes Association. Standards of medical care in diabetes – 2014. Diabetes Care. 2014;37(Suppl 1):S14–S80. doi:10.2337/dc14-S014
  • Aspelund T, Thornorisdottir O, Olafsdottir E, et al. Individual risk assessment and information technology to optimise screening frequency for diabetic retinopathy. Diabetologia. 2011;54(10):2525–2532. doi:10.1007/s00125-011-2257-7
  • Gangwani RA, Lian JX, McGhee SM, Wong D, Li KK. Diabetic retinopathy screening: global and local perspective. Hong Kong Med J. 2016;22(5):486–495. doi:10.12809/hkmj164844
  • Klein R, Klein BE, Neider MW, Hubbard LD, Meuer SM, Brothers RJ. Diabetic retinopathy as detected using ophthalmoscopy, a nonmydriatic camera and a standard fundus camera. Ophthalmology. 1985;92(4):485–491. doi:10.1016/S0161-6420(85)34003-4
  • Mansberger SL, Gleitsmann K, Gardiner S, et al. Comparing the effectiveness of telemedicine and traditional surveillance in providing diabetic retinopathy screening examinations: a randomized controlled trial. Telemed J E Health. 2013;19(12):942–948. doi:10.1089/tmj.2012.0313
  • Shi L, Wu H, Dong J, Jiang K, Lu X, Shi J. Telemedicine for detecting diabetic retinopathy: a systematic review and meta-analysis. Br J Ophthalmol. 2015;99(6):823–831. doi:10.1136/bjophthalmol-2014-305631
  • Pasquel FJ, Hendrick AM, Ryan M, Cason E, Ali MK, Narayan KM. Cost-effectiveness of different diabetic retinopathy screening modalities. J Diabetes Sci Technol. 2016;10(2):301–307. doi:10.1177/1932296815624109
  • Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs -an extension of the modified Airlie House classification. ETDRS report number 10. Ophthalmology. 1991;98(5 Suppl):786–806. doi:10.1016/S0161-6420(13)38012-9
  • Williams GA, Scott IU, Haller JA, Maguire AM, Marcus D, McDonald HR. Single-field fundus photography for diabetic retinopathy screening: a report by the American Academy of Ophthalmology. Ophthalmology. 2004;111(5):1055–1062. doi:10.1016/j.ophtha.2004.02.004
  • Lee JC, Nguyen L, Hynan LS, Blomquist PH. Comparison of 1-field, 2-fields, and 3-fields fundus photography for detection and grading of diabetic retinopathy. J Diabetes Complications. 2019;33(12):107441. doi:10.1016/j.jdiacomp.2019.107441
  • Srihatrai P, Hlowchitsieng T. The diagnostic accuracy of single- and five-field fundus photography in diabetic retinopathy screening by primary care physicians. Indian J Ophthalmol. 2018;66(1):94–97. doi:10.4103/ijo.IJO_657_17
  • Martinez J, Hernandez-Bogantes E, Wu L. Diabetic retinopathy screening using single-field digital fundus photography at a district level in Costa Rica: a pilot study. Int Ophthalmol. 2011;31(2):83–88. doi:10.1007/s10792-010-9413-9
  • Ryan ME, Rajalakshmi R, Prathiba V, et al. Comparison Among Methods of Retinopathy Assessment (CAMRA) Study: smartphone, nonmydriatic, and mydriatic photography. Ophthalmology. 2015;122(10):2038–2043. doi:10.1016/j.ophtha.2015.06.011
  • Vujosevic S, Benetti E, Massignan F, et al. Screening for diabetic retinopathy: 1 and 3 nonmydriatic 45-degree digital fundus photographs vs 7 standard early treatment diabetic retinopathy study fields. Am J Ophthalmol. 2009;148(1):111–118. doi:10.1016/j.ajo.2009.02.031
  • Aptel F, Denis P, Rouberol F, Thivolet C. Screening of diabetic retinopathy: effect of field number and mydriasis on sensitivity and specificity of digital fundus photography. Diabetes Metab. 2008;34(3):290–293. doi:10.1016/j.diabet.2007.12.007
  • Maamari RN, Keenan JD, Fletcher DA, Margolis TP. A mobile phone-based retinal camera for portable wide field imaging. Br J Ophthalmol. 2014;98(4):438–441. doi:10.1136/bjophthalmol-2013-303797
  • Rajalakshmi R, Subashini R, Anjana RM, Mohan V. Automated diabetic retinopathy detection in smartphone-based fundus photography using artificial intelligence. Eye (Lond). 2018;32(6):1138–1144. doi:10.1038/s41433-018-0064-9
  • Toslak D, Liu C, Alam MN, Yao X. Near-infrared light-guided miniaturized indirect ophthalmoscopy for nonmydriatic wide-field fundus photography. Opt Lett. 2018;43(11):2551–2554. doi:10.1364/OL.43.002551
  • Zhang W, Nicholas P, Schuman SG, et al. Screening for diabetic retinopathy using a portable, noncontact, nonmydriatic handheld retinal camera. J Diabetes Sci Technol. 2017;11(1):128–134. doi:10.1177/1932296816658902
  • Chen M, Swinney C, Chen M, Bal M, Nakatsuka A. Comparing the utility of the non-mydriatic fundus camera to the direct ophthalmoscope for medical education. Hawaii J Med Public Health. 2015;74(3):93–95.
  • Shen BY, Mukai S. A portable, inexpensive, nonmydriatic fundus camera based on the raspberry Pi(R) computer. J Ophthalmol. 2017;2017:4526243. doi:10.1155/2017/4526243
  • Wadhwani M, Vashist P, Singh SS, et al. Diabetic retinopathy screening programme utilising non-mydriatic fundus imaging in slum populations of New Delhi, India. Trop Med Int Health. 2018;23(4):405–414. doi:10.1111/tmi.13039
  • Primary Care Optometry News. Software-based vision kiosks help generate new patients; 2009. Available from: https://www.healio.com/news/optometry/20120225/software-based-vision-kiosks-help-generate-new-patients. Accessed July 15, 2020.
  • Pursuant Health. American Diabetes Association and Pursuant Health announce multi-year agreement to include diabetes risk test in national health kiosk network at pharmacies nationwide; 2016. Available from: https://pursuanthealth.com/diabetes-risk-test/. Accessed July 15, 2020.
  • Ng G, Tan SW, Tan NC. Health outcomes of patients with chronic disease managed with a healthcare kiosk in primary care: protocol for a pilot randomised controlled trial. BMJ Open. 2018;8(3):e020265. doi:10.1136/bmjopen-2017-020265
  • Kaiser Health News. Your doctor will see you in this telemedicine kiosk; 2016. Available from: https://www.medscape.com/viewarticle/865164. Accessed July 15, 2020.
  • von Wendt G, Rönnholm P, Heikkilä K, Summanen P. A comparison between one- and two-field 60 degree fundus photography when screening for diabetic retinopathy. Acta Ophthalmol Scand. 2000;78(1):14–20. doi:10.1034/j.1600-0420.2000.078001014.x
  • Silva PS, Cavallerano JD, Tolls D, et al. Potential efficiency benefits of nonmydriatic ultrawide field retinal imaging in an ocular telehealth diabetic retinopathy program. Diabetes Care. 2014;37(1):50–55. doi:10.2337/dc13-1292
  • Silva PS, Horton MB, Clary D, et al. Identification of diabetic retinopathy and ungradable image rate with ultrawide field imaging in a national teleophthalmology program. Ophthalmology. 2016;123(6):1360–1367. doi:10.1016/j.ophtha.2016.01.043
  • Silva PS, Cavallerano JD, Haddad NM, et al. Peripheral lesions identified on ultrawide field imaging predict increased risk of diabetic retinopathy progression over 4 years. Ophthalmology. 2015;122(5):949–956. doi:10.1016/j.ophtha.2015.01.008
  • Lai KHW, Lee RPW, Yiu EPF. Ultrawide-field retinal selfie by smartphone, high-definition television, and a novel clip-on lens. Ophthalmology. 2018;125(7):1027. doi:10.1016/j.ophtha.2018.03.027
  • Al-Otaibi H, Al-Otaibi MD, Khandekar R, et al. Validity, usefulness and cost of RETeval system for diabetic retinopathy screening. Transl Vis Sci Technol. 2017;6(3):3. doi:10.1167/tvst.6.3.3
  • Maa AY, Feuer WJ, Davis CQ, et al. A novel device for accurate and efficient testing for vision-threatening diabetic retinopathy. J Diabetes Complications. 2016;30(3):524–532. doi:10.1016/j.jdiacomp.2015.12.005
  • Park JC, Chen YF, Blair NP, et al. Pupillary responses in non-proliferative diabetic retinopathy. Sci Rep. 2017;7:44987. doi:10.1038/srep44987
  • Jain M, Devan S, Jaisankar D, Swaminathan G, Pardhan S, Raman R. Pupillary abnormalities with varying severity of diabetic retinopathy. Sci Rep. 2018;8(1):5636. doi:10.1038/s41598-018-24015-9
  • Sdobnikova SV, Dorokhina N, Gupalo OD, Krivosheeva NV. Pupillary reactions and eye hemodynamics in patients with diabetes mellitus with different glycemic levels. Vestn Oftalmol. 2010;126(4):10–14.
  • Chang LY, Turuwhenua J, Qu TY, Black JM, Acosta ML. Infrared video pupillography coupled with smart phone LED for measurement of pupillary light reflex. Front Integr Neurosci. 2017;11:6. doi:10.3389/fnint.2017.00006
  • McAnany JJ, Smith BM, Garland A, Kagen SL. iPhone-based pupillometry: a novel approach for assessing the pupillary light reflex. Optom Vis Sci. 2018;95(10):953–958. doi:10.1097/OPX.0000000000001289
  • Ullah W, Pathan SK, Panchal A, et al. Cost-effectiveness and diagnostic accuracy of telemedicine in macular disease and diabetic retinopathy: a systematic review and meta-analysis. Medicine (Baltimore). 2020;99(25):e20306. doi:10.1097/MD.0000000000020306
  • Schulze-Döbold C, Erginay A, Robert N, Chabouis A, Massin P. Ophdiat®: five-year experience of a telemedical screening programme for diabetic retinopathy in Paris and the surrounding area. Diabetes Metab. 2012;38(5):450–457. doi:10.1016/j.diabet.2012.05.003
  • Wong IYH, Ni MY, Wong IOL, Fong N, Leung GM. Saving sight in China and beyond: the Lifeline Express model. BMJ Glob Health. 2018;3(4):e000766. doi:10.1136/bmjgh-2018-000766
  • Melles RB, Conell C, Siegner SW, Tarasewicz D. Diabetic retinopathy screening using a virtual reading center. Acta Diabetol. 2020;57(2):183–188. doi:10.1007/s00592-019-01392-9
  • Kalogeropoulos D, Kalogeropoulos C, Stefaniotou M, Neofytou M. The role of tele-ophthalmology in diabetic retinopathy screening. J Optom. 2020. doi:10.1016/j.optom.2019.12.004
  • Li Z, Wu C, Olayiwola JN, Hilaire DS, Huang JJ. Telemedicine-based digital retinal imaging vs standard ophthalmologic evaluation for the assessment of diabetic retinopathy. Conn Med. 2012;76(2):85–90.
  • Glasson NM, Crossland LJ, Larkins SL. An innovative australian outreach model of diabetic retinopathy screening in remote communities. J Diabetes Res. 2016;2016:1267215. doi:10.1155/2016/1267215
  • Bai VT, Murali V, Kim R, Srivatsa SK. Teleophthalmology-based rural eye care in India. Telemed J E Health. 2007;13(3):313–321. doi:10.1089/tmj.2006.0048
  • Bellemo V, Lim G, Rim TH, et al. Artificial intelligence screening for diabetic retinopathy: the real-world emerging application. Curr Diab Rep. 2019;19(9):72. doi:10.1007/s11892-019-1189-3
  • Ramachandran N, Hong SC, Sime MJ, Wilson GA. Diabetic retinopathy screening using deep neural network. Clin Exp Ophthalmol. 2018;46(4):412–416. doi:10.1111/ceo.13056
  • Heydon P, Egan C, Bolter L. et al. Prospective evaluation of an artificial intelligence-enabled algorithm for automated diabetic retinopathy screening of 30 000 patients. Br J Ophthalmol. 2020. doi:10.1136/bjophthalmol-2020-316594
  • Ting DSW, Cheung CY, Lim G, et al. Development and validation of a deep learning system for diabetic retinopathy and related eye diseases using retinal images from multiethnic populations with diabetes. JAMA. 2017;318(22):2211–2223. doi:10.1001/jama.2017.18152
  • van der Heijden AA, Abramoff MD, Verbraak F, van Hecke MV, Liem A, Nijpels G. Validation of automated screening for referable diabetic retinopathy with the IDx-DR device in the Hoorn Diabetes Care System. Acta Ophthalmol. 2018;96(1):63–68. doi:10.1111/aos.13613
  • Natarajan S, Jain A, Krishnan R, Rogye A, Sivaprasad S. Diagnostic accuracy of community-based diabetic retinopathy screening with an offline artificial intelligence system on a smartphone. JAMA Ophthalmol. 2019;137(10):1182–1188. doi:10.1001/jamaophthalmol.2019.2923
  • Bhaskaranand M, Ramachandra C, Bhat S, et al. The value of automated diabetic retinopathy screening with the eyeart system: A study of more than 100,000 consecutive encounters from people with diabetes. Diabetes Technol Ther. 2019;21(11):635–643. doi:10.1089/dia.2019.0164
  • Peng L. Assessing cardiovascular risk factors with computer vision; 2018. Available from: https://ai.googleblog.com/2018/02/assessing-cardiovascular-risk-factors.html. Accessed July 15, 2020.
  • James M, Turner DA, Broadbent DM, Vora J, Harding SP. Cost effectiveness analysis of screening for sight threatening diabetic eye disease. BMJ. 2000;320(7250):1627–1631. doi:10.1136/bmj.320.7250.1627
  • Millett C, Dodhia H. Diabetes retinopathy screening: audit of equity in participation and selected outcomes in South East London. J Med Screen. 2006;13(3):152–155. doi:10.1258/096914106778440608
  • Waqar S, Bullen G, Chant S, Salman R, Vaidya B, Ling R. Cost implications, deprivation and geodemographic segmentation analysis of non-attenders (DNA) in an established diabetic retinopathy screening programme. Diabetes Metab Syndr. 2012;6(4):199–202. doi:10.1016/j.dsx.2012.08.009
  • Bjørvig S, Johansen MA, Fossen K. An economic analysis of screening for diabetic retinopathy. J Telemed Telecare. 2002;8(1):32–35. doi:10.1258/1357633021937433
  • Al-Shakarchi FI. Blindness in iraq: leading causes, target patients, and barriers to treatment. Middle East Afr J Ophthalmol. 2011;18(3):199–203. doi:10.4103/0974-9233.84044
  • Keenum Z, McGwin G Jr., Witherspoon CD, Haller JA, Clark ME, Owsley C. Patients’ adherence to recommended follow-up eye care after diabetic retinopathy screening in a publicly funded county clinic and factors associated with follow-up eye care use. JAMA Ophthalmol. 2016;134(11):1221–1228. doi:10.1001/jamaophthalmol.2016.3081
  • Lewis K, Patel D, Yorston D, Charteris D. A qualitative study in the United Kingdom of factors influencing attendance by patients with diabetes at ophthalmic outpatient clinics. Ophthalmic Epidemiol. 2007;14(6):375–380. doi:10.1080/09286580701375195
  • Cavan D, Makaroff LE, da Rocha Fernandes J, et al. Global perspectives on the provision of diabetic retinopathy screening and treatment: survey of health care professionals in 41 countries. Diabetes Res Clin Pract. 2018;143:170–178. doi:10.1016/j.diabres.2018.07.004
  • Cavan D, Makaroff L, da Rocha Fernandes J, et al. The Diabetic Retinopathy Barometer Study: global perspectives on access to and experiences of diabetic retinopathy screening and treatment. Diabetes Res Clin Pract. 2017;129:16–24. doi:10.1016/j.diabres.2017.03.023
  • Lawrenson JG, Graham-Rowe E, Lorencatto F, et al. Interventions to increase attendance for diabetic retinopathy screening. Cochrane Database Syst Rev. 2018;1:CD012054.
  • Basch CE, Walker EA, Howard CJ, Shamoon H, Zybert P. The effect of health education on the rate of ophthalmic examinations among African Americans with diabetes mellitus. Am J Public Health. 1999;89(12):1878–1882. doi:10.2105/AJPH.89.12.1878
  • Zangalli CS, Murchison AP, Hale N, et al. An education- and telephone-based intervention to improve follow-up to vision care in patients with diabetes: a prospective, single-blinded, randomized trial. Am J Med Qual. 2016;31(2):156–161. doi:10.1177/1062860614552670
  • Mumba M, Hall A, Lewallen S. Compliance with eye screening examinations among diabetic patients at a Tanzanian referral hospital. Ophthalmic Epidemiol. 2007;14(5):306–310. doi:10.1080/09286580701272079
  • Lake AJ, Browne JL, Abraham C, et al. A tailored intervention to promote uptake of retinal screening among young adults with type 2 diabetes - an intervention mapping approach. BMC Health Serv Res. 2018;18(1):396. doi:10.1186/s12913-018-3188-5
  • Orton E, Forbes-Haley A, Tunbridge L, Cohen S. Equity of uptake of a diabetic retinopathy screening programme in a geographically and socio-economically diverse population. Public Health. 2013;127(9):814–821. doi:10.1016/j.puhe.2013.04.015
  • Lu Y, Serpas L, Genter P, Anderson B, Campa D, Ipp E. Divergent perceptions of barriers to diabetic retinopathy screening among patients and care providers, Los Angeles, California, 2014–2015. Prev Chronic Dis. 2016;13:E140. doi:10.5888/pcd13.160193
  • Walker EA, Schechter CB, Caban A, Basch CE. Telephone intervention to promote diabetic retinopathy screening among the urban poor. Am J Prev Med. 2008;34(3):185–191. doi:10.1016/j.amepre.2007.11.020
  • Macon C, Carrier H, Janczewski A, Verger P, Casanova L. Effect of automobile travel time between patients’ homes and ophthalmologists’ offices on screening for diabetic retinopathy. Telemed J E Health. 2018;24(1):11–20. doi:10.1089/tmj.2016.0271
  • Law MG, Komura S, Murchison AP, Pizzi LT. Pharmacy staff opinions regarding diabetic retinopathy screenings in the community setting: findings from a brief survey. Am Health Drug Benefits. 2013;6(9):548–552.
  • Rosses APO, Ben AJ, Souza CF, et al. Diagnostic performance of retinal digital photography for diabetic retinopathy screening in primary care. Fam Pract. 2017;34(5):546–551. doi:10.1093/fampra/cmx020
  • Daskivich LP, Vasquez C, Martinez C Jr., Tseng CH, Mangione CM. Implementation and evaluation of a large-scale teleretinal diabetic retinopathy screening program in the Los Angeles county department of health services. JAMA Intern Med. 2017;177(5):642–649. doi:10.1001/jamainternmed.2017.0204
  • Shah M, Noor A, Deverell L, Ormsby GM, Harper CA, Keeffe JE. Task sharing in the eye care workforce: screening, detection, and management of diabetic retinopathy in Pakistan. A case study. Int J Health Plann Manage. 2018;33(3):627–636. doi:10.1002/hpm.2508
  • Facey K, Cummins E, MacPherson K, Morris A, Reay L, Slattery J. Organisation of services for diabetic retinopathy screening. Health Technology Assessment Report 1. Glasgow: Health Technology Board for Scotland; 2002.
  • Strutton R, Du Chemin A, Stratton IM, Forster AS. System-level and patient-level explanations for non-attendance at diabetic retinopathy screening in Sutton and Merton (London, UK): a qualitative analysis of a service evaluation. BMJ Open. 2016;6(5):e010952. doi:10.1136/bmjopen-2015-010952
  • Dutra Medeiros M, Mesquita E, Gardete-Correia L, et al. First incidence and progression study for diabetic retinopathy in Portugal, the RETINODIAB study: evaluation of the screening program for Lisbon region. Ophthalmology. 2015;122(12):2473–2481. doi:10.1016/j.ophtha.2015.08.004
  • Dutra Medeiros M, Mesquita E, Papoila AL, Genro V, Raposo JF. First diabetic retinopathy prevalence study in Portugal: RETINODIAB Study–evaluation of the screening programme for Lisbon and Tagus Valley region. Br J Ophthalmol. 2015;99(10):1328–1333. doi:10.1136/bjophthalmol-2015-306727
  • Scanlon PH, Provins EK, Craske S, et al. Updating diabetic retinopathy screening lists using automatic extraction from GP patient records. J Med Screen. 2013;20(3):111–117. doi:10.1177/0969141313505747
  • Leese GP, Boyle P, Feng Z, Emslie-Smith A, Ellis JD. Screening uptake in a well-established diabetic retinopathy screening program: the role of geographical access and deprivation. Diabetes Care. 2008;31(11):2131–2135. doi:10.2337/dc08-1098
  • Moreton RBR, Stratton IM, Chave SJ, Lipinski H, Scanlon PH. Factors determining uptake of diabetic retinopathy screening in Oxfordshire. Diabet Med. 2017;34(7):993–999. doi:10.1111/dme.13350
  • Moynihan V, Turner A. Coordination of diabetic retinopathy screening in the Kimberley region of Western Australia. Aust J Rural Health. 2017;25(2):110–115. doi:10.1111/ajr.12290
  • Oster RT, Virani S, Strong D, Shade S, Toth EL. Diabetes care and health status of First Nations individuals with type 2 diabetes in Alberta. Can Fam Physician. 2009;55(4):386–393.
  • Spurr S, Bullin C, Bally J, Trinder K, Khan S. Nurse-led diabetic retinopathy screening: a pilot study to evaluate a new approach to vision care for Canadian Aboriginal peoples. Int J Circumpolar Health. 2018;77(1):1422670. doi:10.1080/22423982.2017.1422670
  • Phan AD, Koczman JJ, Yung CW, Pernic AA, Doerr ED, Kaehr MM. Cost analysis of teleretinal screening for diabetic retinopathy in a county hospital population. Diabetes Care. 2014;37(12):e252–253. doi:10.2337/dc14-0929
  • French DD, Behrens JJ, Jackson KL, et al. Payment reform needed to address health disparities of undiagnosed diabetic retinopathy in the City of Chicago. Ophthalmol Ther. 2017;6(1):123–131. doi:10.1007/s40123-016-0072-4
  • Braithwaite T, Winford B, Bailey H, et al. Health system dynamics analysis of eyecare services in Trinidad and Tobago and progress towards Vision 2020 Goals. Health Policy Plan. 2018;33(1):70–84. doi:10.1093/heapol/czx143
  • Sheppler CR, Lambert WE, Gardiner SK, Becker TM, Mansberger SL. Predicting adherence to diabetic eye examinations: development of the Compliance with Annual Diabetic Eye Exams Survey. Ophthalmology. 2014;121(6):1212–1219. doi:10.1016/j.ophtha.2013.12.016
  • Judah G, Darzi A, Vlaev I, et al. Financial disincentives? A three-armed randomised controlled trial of the effect of financial Incentives in Diabetic Eye Assessment by Screening (IDEAS) trial. Br J Ophthalmol. 2018;102(8):1014–1020. doi:10.1136/bjophthalmol-2017-311778
  • Khan T, Bertram MY, Jina R, Mash B, Levitt N, Hofman K. Preventing diabetes blindness: cost effectiveness of a screening programme using digital non-mydriatic fundus photography for diabetic retinopathy in a primary health care setting in South Africa. Diabetes Res Clin Pract. 2013;101(2):170–176. doi:10.1016/j.diabres.2013.05.006
  • Lee SJ, McCarty CA, Taylor HR, Keeffe JE. Costs of mobile screening for diabetic retinopathy: a practical framework for rural populations. Aust J Rural Health. 2001;9(4):186–192. doi:10.1046/j.1038-5282.2001.00356.x